-
Tech, Semiconductors Among Worst Performers As Sell-Off Continues
Friday, October 10, 2014 - 5:06pm | 2294Read More...U.S. stocks continued to sell off on Friday on higher than usual volume. Semiconductor stocks were hit hard following Microchip's profit warning and cautious sector-wide comments. The rest of the tech sector was weak, especially "momentum" and high-beta stocks as the Nasdaq index...
-
Barron's Recap: Bad News For Putin
Monday, March 31, 2014 - 6:48am | 822Read More...This weekend in Barron's online: the effects of oil at $75 a barrel, the next stage of Obamacare, as well as the prospects for Tesla's Gigafactory, DDR, Exact Sciences and more. Cover Story "Here Comes $75 Oil" by Gene Epstein. The long-term outlook for global oil prices is lower, says this week...
-
Illumina and Other Bargain Biotech Stocks Worth a Look Now
Wednesday, May 1, 2013 - 12:57pm | 916Read More...The research team at PropThink, which focuses on emerging growth companies in the health care sector, recently offered a list of bargain biotech stocks worth a look. The stocks that made the list include Endo Health Solutions (NASDAQ: ENDP), Illumina (NASDAQ: ILMN) and Keryx Biopharmaceuticals (...
-
Barron's Recap (10/6/12): Out of the Storm
Monday, October 8, 2012 - 6:33am | 865Read More...This past weekend in Barron's online: a profile of fund manager Neuberger Berman, the prospects for Viacom, Brink's and closed-end funds, and takeaways from last week's presidential debate. Cover Story "Fair Winds Ahead" by Michael Santoli. Asset manager Neuberger Berman was tied to Lehman...
-
EXACT Sciences Building A Better Screening Test - Initiating With A Buy And $10 Target
Tuesday, March 1, 2011 - 8:48am | 150Read More...According to Auriga, EXACT Sciences Corp. (NASDAQ: EXAS) is building a better screening test and initiating with a Buy and $10 target. Auriga reported that EXAS is developing Cologuard, a stool-based test for Colorectal Cancer (CRC) screening, a potential $1 billion-plus market opportunity. “...
-
Rodman & Renshaw Changes Price Targets on China Power Equipment and EXACT Sciences
Tuesday, November 16, 2010 - 11:00am | 31Read More...Rodman & Renshaw has decreased the price target on China Power Equipment (OTC BB: CPQQ.QB) from $6 to $5. Rodman & Renshaw has increased the price target on EXACT Sciences (NasdaqCM: EXAS) to $7 from $6.
